Find link

language:

Find link is a tool written by Edward Betts.

Longer titles found: Glucagon-like peptide-1 receptor (view)

searching for Glucagon-like peptide-1 59 found (148 total)

GLP-1 receptor agonist (3,979 words) [view diff] exact match in snippet view article find links to article

Glucagon-like peptide-1 (GLP-1) receptor agonists, also known as GLP-1 analogs, GLP-1DAs or incretin mimetics, are a class of drugs that reduce blood

Albiglutide (1,096 words) [view diff] exact match in snippet view article find links to article

Albiglutide (trade names Eperzan in Europe and Tanzeum in the US) is a glucagon-like peptide-1 agonist (GLP-1 agonist) drug marketed by GlaxoSmithKline (GSK)

Taspoglutide (359 words) [view diff] exact match in snippet view article find links to article

Taspoglutide is a former experimental drug, a glucagon-like peptide-1 agonist (GLP-1 agonist), that was under investigation for treatment of type 2 diabetes

ATC code A10 (508 words) [view diff] no match in snippet view article find links to article

ATC code A10 Drugs used in diabetes is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes

Dipeptidyl peptidase-4 inhibitor (1,798 words) [view diff] no match in snippet view article find links to article

metformin concomitantly with additive effect to increase the level of glucagon-like peptide 1 (GLP-1) which also decreases hepatic glucose production.[citation

Efocipegtrutide (198 words) [view diff] no match in snippet view article find links to article

Efocipegtrutide (HM15211) is a triple agonist of the glucagon, GIP, and glucagon-like peptide 1 receptors. It is being studied for obesity and nonalcoholic steatohepatitis

Peptide therapeutics (2,768 words) [view diff] exact match in snippet view article find links to article

(September 2013). "Self-assembling peptides improve the stability of glucagon-like peptide-1 by forming a stable and sustained complex". Molecular Pharmaceutics

Orforglipron (171 words) [view diff] exact match in snippet view article find links to article

Orforglipron (LY-3502970) is a non-peptide glucagon-like peptide-1 receptor agonist developed as a weight loss drug by Eli Lilly and Company. It is easier

Lotiglipron (83 words) [view diff] exact match in snippet view article find links to article

Lotiglipron is a non-peptide glucagon-like peptide-1 receptor agonist developed as a weight loss drug by Pfizer. It was withdrawn from development after

Eriocitrin (928 words) [view diff] no match in snippet view article find links to article

nutraceutical Eriocitrin (Eriomin) in reducing hyperglycemia by increasing glucagon-like peptide 1 and downregulates systemic inflammation. This double-blind, randomized

RosePharma (449 words) [view diff] exact match in snippet view article find links to article

Björnssön, E; Kristensen, J; Schambye, H (2009). "Clinical trial: The glucagon-like peptide-1 analogue ROSE-010 for management of acute pain in patients with

Hanmi Pharm (1,396 words) [view diff] exact match in snippet view article find links to article

license outside of South Korea and China with Sanofi for Hanmi's Glucagon-like peptide-1 receptor agonist drug candidates for diabetes; Sanofi paid $434

9-Phenanthrol (106 words) [view diff] no match in snippet view article find links to article

(2017). "A TRPM4 Inhibitor 9-Phenanthrol Inhibits Glucose- and Glucagon-Like Peptide 1-Induced Insulin Secretion from Rat Islets of Langerhans". Journal

GNAT3 (617 words) [view diff] exact match in snippet view article find links to article

"Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1". Proc. Natl. Acad. Sci. U.S.A. 104 (38): 15069–74. Bibcode:2007PNAS

Mannoheptulose (609 words) [view diff] no match in snippet view article find links to article

Anna Kate (2015). "Dietary Mannoheptulose Increases Fasting Serum Glucagon Like Peptide-1 and Post-Prandial Serum Ghrelin Concentrations in Adult Beagle

Efinopegdutide (251 words) [view diff] exact match in snippet view article find links to article

Ruchika (April 2023). "Emerging roles of oxyntomodulin-based glucagon-like peptide-1/glucagon co-agonist analogs in diabetes and obesity". Peptides

HRS9531 (174 words) [view diff] exact match in snippet view article find links to article

Goldenberg, Ronald M.; Teoh, Hwee; Verma, Subodh (November 2023). "Glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide receptor co-agonists

Omarigliptin (343 words) [view diff] no match in snippet view article find links to article

S2CID 9151210. Behme MT, Dupré J, McDonald TJ (April 2003). "Glucagon-like peptide 1 improved glycemic control in type 1 diabetes". BMC Endocrine Disorders

Cinchonine (192 words) [view diff] case mismatch in snippet view article find links to article

Yun-Feng (11 May 2023). "Cinchonine, a Potential Oral Small-Molecule Glucagon-Like Peptide-1 Receptor Agonist, Lowers Blood Glucose and Ameliorates Non-Alcoholic

Danuglipron (190 words) [view diff] case mismatch in snippet view article find links to article

et al. (June 2022). "A Small-Molecule Oral Agonist of the Human Glucagon-like Peptide-1 Receptor". Journal of Medicinal Chemistry. 65 (12): 8208–8226.

VK2735 (170 words) [view diff] exact match in snippet view article find links to article

Goldenberg, Ronald M.; Teoh, Hwee; Verma, Subodh (2023-08-21). "Glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide receptor co-agonists

Hepatocyte (1,584 words) [view diff] exact match in snippet view article find links to article

Wilson CH, Tallis GA, Zhou FH, Rychkov GY, Barritt GJ (2016). "The glucagon-like peptide-1 analogue exendin-4 reverses impaired intracellular Ca2+ signalling

ICAM2 (1,211 words) [view diff] exact match in snippet view article find links to article

Nam TW, Ko G (May 2021). "Akkermansia muciniphila secretes a glucagon-like peptide-1-inducing protein that improves glucose homeostasis and ameliorates

Insulin degludec/liraglutide (475 words) [view diff] exact match in snippet view article find links to article

degludec/liraglutide Combination of Insulin degludec Insulin analog Liraglutide Glucagon-like peptide-1 receptor agonist (GLP-1) Clinical data Trade names Xultophy AHFS/Drugs

NNC9204-1706 (288 words) [view diff] no match in snippet view article find links to article

Mathies M.; Christensen, Mikkel B. (September 2021). "Emerging glucagon-like peptide 1 receptor agonists for the treatment of obesity". Expert Opinion

Ecnoglutide (327 words) [view diff] exact match in snippet view article find links to article

"Discovery of ecnoglutide – A novel, long-acting, cAMP-biased glucagon-like peptide-1 (GLP-1) analog". Molecular Metabolism. 75: 101762. doi:10.1016/j

Penetration enhancer (1,058 words) [view diff] exact match in snippet view article find links to article

(2018-11-14). "Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist". Science Translational Medicine. 10 (467). doi:10

Cyclic adenosine monophosphate (1,612 words) [view diff] exact match in snippet view article find links to article

Wilson CH, Tallis GA, Zhou FH, Rychkov GY, Barritt GJ (2016). "The glucagon-like peptide-1 analogue exendin-4 reverses impaired intracellular Ca2+ signalling

Amylin Pharmaceuticals (1,234 words) [view diff] no match in snippet view article find links to article

Retrieved 2017-05-26. Garber, Alan J. (2011-05-01). "Long-Acting Glucagon-Like Peptide 1 Receptor Agonists". Diabetes Care. 34 (Supplement 2): S279–S284

Insulin icodec/semaglutide (97 words) [view diff] no match in snippet view article find links to article

Saptarshi; Kapoor, Nitin (August 2021). "Contemporary Classification of Glucagon-Like Peptide 1 Receptor Agonists (GLP1RAs)". Diabetes Therapy. 12 (8): 2133–2147

Free fatty acid receptor 2 (8,749 words) [view diff] exact match in snippet view article find links to article

intestinal L-cells. This stimules these cells to secrete GLP-1 (i.e., glucagon-like peptide-1) and PYY (i.e., peptide YY) into the blood. GLP-1 stimulates pancreatic

Insulin glargine/lixisenatide (1,438 words) [view diff] exact match in snippet view article find links to article

Combination of Insulin glargine Long acting insulin Lixisenatide Glucagon-like peptide-1 receptor agonist Clinical data Trade names Soliqua, Suliqua, others

MariTide (187 words) [view diff] no match in snippet view article find links to article

Jepsen, Mathies M.; Christensen, Mikkel B. (3 July 2021). "Emerging glucagon-like peptide 1 receptor agonists for the treatment of obesity". Expert Opinion

Robert Margolskee (736 words) [view diff] exact match in snippet view article find links to article

"Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1". Proceedings of the National Academy of Sciences USA. 104 (38):

Carboxypeptidase E (1,883 words) [view diff] exact match in snippet view article find links to article

Holst JJ (June 2001). "Attenuated processing of proglucagon and glucagon-like peptide-1 in carboxypeptidase E-deficient mice". The Journal of Endocrinology

Calcium signaling (2,271 words) [view diff] exact match in snippet view article find links to article

Tallis GA, Zhou FH, Rychkov GY, Barritt GJ (September 2016). "The glucagon-like peptide-1 analogue exendin-4 reverses impaired intracellular Ca(2+) signalling

Ryanodine receptor (2,290 words) [view diff] exact match in snippet view article find links to article

Holz GG, Jouaville LS, Thomas AP, Rutter GA (January 2003). "Glucagon-like peptide-1 mobilizes intracellular Ca2+ and stimulates mitochondrial ATP synthesis

Bile acid malabsorption (2,525 words) [view diff] no match in snippet view article find links to article

Bile Acid Malabsorption Symptoms Following Treatment With the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide". Gastroenterology. 157 (2): 569–571

Cyclic nucleotide (2,416 words) [view diff] exact match in snippet view article find links to article

(January 2004). "Epac: A new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell"

Protein kinase C (2,650 words) [view diff] exact match in snippet view article find links to article

Wilson CH, Tallis GA, Zhou FH, Rychkov GY, Barritt GJ (2016). "The glucagon-like peptide-1 analogue exendin-4 reverses impaired intracellular Ca2+ signalling

Type 2 diabetes (12,151 words) [view diff] case mismatch in snippet view article find links to article

2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists : A Cost-Effectiveness Study". Annals of Internal

Ted M. Dawson (2,746 words) [view diff] exact match in snippet view article find links to article

(LAG3). In further collaborative studies, they discovered that Glucagon-like peptide-1 receptor (GLP1R) agonist, NLY01, prevents neuroinflammaory damage

Insulin signal transduction pathway (3,157 words) [view diff] exact match in snippet view article find links to article

2003). "Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2". Canadian Journal of Physiology and

Metabolic syndrome (6,651 words) [view diff] exact match in snippet view article find links to article

Tallis GA, Zhou FH, Rychkov GY, Barritt GJ (September 2016). "The glucagon-like peptide-1 analogue exendin-4 reverses impaired intracellular Ca(2+) signalling

Anti-obesity medication (5,009 words) [view diff] case mismatch in snippet view article find links to article

Medication: Gastrointestinal Agents, Other, CNS Stimulants, Anorexiants, Glucagon-like Peptide-1 Agonists, Antidepressants, dopamine reuptake inhibitors; opioid

Respirometry (3,817 words) [view diff] no match in snippet view article find links to article

N., Waget A., Pénicaud L., Valet P., Burcelin R., 2008. Brain glucagon-like peptide 1 signaling controls the onset of high-fat diet-induced insulin resistance

SGLT2 inhibitor (4,552 words) [view diff] no match in snippet view article find links to article

"Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors with All-Cause

Mazdutide (284 words) [view diff] exact match in snippet view article find links to article

Wenying (24 June 2022). "A phase 1b randomised controlled trial of a glucagon-like peptide-1 and glucagon receptor dual agonist IBI362 (LY3305677) in Chinese

Roberta Gottlieb (2,105 words) [view diff] exact match in snippet view article find links to article

.. & Andres, A. M. (2020). Intermittent use of a short-course glucagon-like peptide-1 receptor agonist therapy limits adverse cardiac remodeling via

Merck & Co. (9,333 words) [view diff] exact match in snippet view article find links to article

CF, Mannucci E, Ahrén B (August 2012). "Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on

Valina L. Dawson (3,374 words) [view diff] exact match in snippet view article find links to article

the lymphocyte-activation gene 3 (LAG3). They discovered that Glucagon-like peptide-1 receptor (GLP1R) agonist, NLY01 prevents neuroinflammatory damage

Childhood obesity (10,254 words) [view diff] exact match in snippet view article find links to article

teratogenic effects of the medication. Liraglutide and semaglutide are glucagon-like peptide-1 receptor agonists which are approved for the treatment of obesity

Eric Klann (1,310 words) [view diff] exact match in snippet view article find links to article

Du, X., Pick, J.E., Sui, G., Brownlee, M., and Klann, E. (2012) Glucagon-like peptide-1 cleavage product GLP-1 (9-36) amide rescues synaptic plasticity

Cocaine (17,673 words) [view diff] exact match in snippet view article find links to article

cocaine administration on serum concentrations of ghrelin, amylin, glucagon-like peptide-1, insulin, leptin and peptide YY and relationships with cardiorespiratory

Ashutosh Chilkoti (2,716 words) [view diff] exact match in snippet view article find links to article

control via zero-order release kinetics from an injectable depot of glucagon-like peptide-1 fused to a thermosensitive biopolymer". Nature Biomedical Engineering

Cultural impact of TikTok (3,597 words) [view diff] no match in snippet view article find links to article

Sarah (4 July 2023). "Public Interest in the Off-Label Use of Glucagon-like Peptide 1 Agonists (Ozempic) for Cosmetic Weight Loss: A Google Trends Analysis"

Christos Socrates Mantzoros (7,174 words) [view diff] exact match in snippet view article find links to article

Bhanu; Savjani, Gopal; Mantzoros, Christos (2021). "Effect of the glucagon-like peptide-1 analogue liraglutide versus placebo treatment on circulating proglucagon-derived

Metabolic dysfunction–associated steatotic liver disease (14,442 words) [view diff] exact match in snippet view article find links to article

liver fibrosis irrespective of whether or not they have diabetes. Glucagon-like peptide-1 receptor agonists are at least as effective as pioglitazone and

TMEM211 (9,001 words) [view diff] no match in snippet view article find links to article

secretion, including melatonin, estrogen, leptin, growth hormone, and glucagon like peptide-1. If any of these result in a non-zero binding rate, an experiment